During the past decade, Research Asthma, Sinus and Allergy Centers conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Research Asthma, Sinus and Allergy Centers" are "Seasonal Allergic Rhinitis" (4 trials), "Allergic Rhinitis" (1 trials) and "Perennial Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Research Asthma, Sinus and Allergy Centers" in a lesser frequency.

Most popular intervention types in "Research Asthma, Sinus and Allergy Centers" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "fluticasone propionate" (3 trials), "azelastine Hcl" (2 trials), "0.1% azelastine hydrochloride 1096 mcg daily" (1 trials) and "0.15% azelastine hydrochloride 1644 mcg daily" (1 trials). Other intervention names were less common.

The vast majority of trials in "Research Asthma, Sinus and Allergy Centers" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Research Asthma, Sinus and Allergy Centers". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Research Asthma, Sinus and Allergy Centers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Research Asthma, Sinus and Allergy Centers, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".